l-carnitine and opioid tolerance Glycine Transporter 1 Inhibitors: Predictions on Their Possible Mechanisms in the Development of Analgesic Tolerance and Withdrawal From Prolonged
Description
10.1111/j.1600-065x.2010.00980.x 101 LopesA.VandermeulenG.PreatV
Women using oral contraceptives should use an additional non-oral contraceptive method for 4 weeks after initiating tirzepatide and for 4 weeks after each dose increase
GG: Writing original draft, Data curation
- patients taking drugs interacting significantly with the study compounds
Do not use during pregnancy or breastfeeding
No changes were seen in OAP or YAG
